ELAPRASE

Welcome to the Brand page for “ELAPRASE”, which is offered here for The mark consists of the word elaprase in lower-case letters, with the first seven letters shown in black and the last letter shown in blue.;pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of hunter's syndrome;the color(s) black and blue is/are claimed as a feature of the mark.;.

Its status is currently believed to be active. Its class is unavailable. “ELAPRASE” is believed to be currently owned by “SHIRE HUMAN GENETIC THERAPIES, INC.”


Owner:
SHIRE HUMAN GENETIC THERAPIES, INC.
Owner Details
Description:
The mark consists of the word ELAPRASE in lower-case letters, with the first seven letters shown in black and the last letter shown in blue.;Pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of Hunter's syndrome;The color(s) black and blue is/are claimed as a feature of the mark.;
Categories: